home / stock / govx / govx quote
Last: | $0.2678 |
---|---|
Change Percent: | -7.66% |
Open: | $0.29 |
Close: | $0.2678 |
High: | $0.29 |
Low: | $0.25 |
Volume: | 409,289 |
Last Trade Date Time: | 09/24/2020 04:53:47 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.2678 | $0.29 | $0.2678 | $0.29 | $0.25 | 409,289 | 09-24-2020 |
$0.29 | $0.32 | $0.29 | $0.34 | $0.282 | 130,589 | 09-23-2020 |
$0.3 | $0.35 | $0.3 | $0.355 | $0.29 | 325,025 | 09-22-2020 |
$0.33 | $0.32 | $0.33 | $0.3363 | $0.3 | 106,043 | 09-21-2020 |
$0.312 | $0.33 | $0.312 | $0.33 | $0.3 | 122,771 | 09-18-2020 |
$0.3 | $0.31 | $0.3 | $0.34 | $0.3 | 368,321 | 09-17-2020 |
$0.323 | $0.32 | $0.323 | $0.325 | $0.3 | 295,097 | 09-16-2020 |
$0.32 | $0.34 | $0.32 | $0.34 | $0.31 | 249,020 | 09-15-2020 |
$0.365 | $0.29 | $0.365 | $0.365 | $0.29 | 428,477 | 09-14-2020 |
$0.29 | $0.32 | $0.29 | $0.3215 | $0.275 | 969,669 | 09-11-2020 |
$0.335 | $0.355 | $0.335 | $0.36 | $0.331 | 271,854 | 09-10-2020 |
$0.36 | $0.4 | $0.36 | $0.4 | $0.35 | 282,550 | 09-09-2020 |
$0.3998 | $0.45 | $0.3998 | $0.45 | $0.36 | 193,709 | 09-08-2020 |
$0.4 | $0.44 | $0.4 | $0.44 | $0.4 | 167,335 | 09-07-2020 |
$0.4 | $0.44 | $0.4 | $0.44 | $0.4 | 167,335 | 09-04-2020 |
$0.438 | $0.4625 | $0.438 | $0.54 | $0.415 | 477,168 | 09-03-2020 |
$0.4525 | $0.4025 | $0.4525 | $0.47 | $0.4025 | 147,173 | 09-02-2020 |
$0.4099 | $0.4593 | $0.4099 | $0.4593 | $0.402 | 141,822 | 09-01-2020 |
$0.4085 | $0.412 | $0.4085 | $0.43 | $0.4 | 153,848 | 08-31-2020 |
$0.429 | $0.43 | $0.429 | $0.445 | $0.4099 | 139,234 | 08-28-2020 |
News, Short Squeeze, Breakout and More Instantly...
ATLANTA, GA - ( NewMediaWire ) - July 11, 2024 - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it has entered into a definitive securities purchase agreement with a cert...
GeoVax Labs, Inc. (NASDAQ: GOVX) is one of today's top gainers. The company's shares have moved 20.05% on the day to $3.02. GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ank...
Award of BARDA Project NextGen contract represents a significant milestone event; total value of award to GeoVax and its CRO partner total approximately $367-388 million BARDA-funded 10,000-participant Phase 2b study will evaluate and compare GeoVax’s ...